Tag: voretigene neparvovec
Spark Therapeutics bags Luxturna EU approval for inherited retinal disease
Luxturna EU approval for inherited retinal disease : Pennsylvania-based Spark Therapeutics has bagged the European Commission’s (EC) approval for its gene therapy Luxturna (voretigene neparvovec) ... Read More